These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 28011126

  • 21. Dry Mechanochemical Synthesis of Caffeine/Oxalic Acid Cocrystals and Their Evaluation by Powder X-Ray Diffraction and Chemometrics.
    Otsuka Y, Ito A, Takeuchi M, Tanaka H.
    J Pharm Sci; 2017 Dec; 106(12):3458-3464. PubMed ID: 28797789
    [Abstract] [Full Text] [Related]

  • 22. Formation Thermodynamics of Carbamazepine with Benzamide, Para-Hydroxybenzamide and Isonicotinamide Cocrystals: Experimental and Theoretical Study.
    Manin AN, Boycov DE, Simonova OR, Volkova TV, Churakov AV, Perlovich GL.
    Pharmaceutics; 2022 Sep 06; 14(9):. PubMed ID: 36145629
    [Abstract] [Full Text] [Related]

  • 23. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals.
    Ren S, Liu M, Hong C, Li G, Sun J, Wang J, Zhang L, Xie Y.
    Acta Pharm Sin B; 2019 Jan 06; 9(1):59-73. PubMed ID: 30766778
    [Abstract] [Full Text] [Related]

  • 24. Optimising the in vitro and in vivo performance of oral cocrystal formulations via spray coating.
    Serrano DR, Walsh D, O'Connell P, Mugheirbi NA, Worku ZA, Bolas-Fernandez F, Galiana C, Dea-Ayuela MA, Healy AM.
    Eur J Pharm Biopharm; 2018 Mar 06; 124():13-27. PubMed ID: 29196273
    [Abstract] [Full Text] [Related]

  • 25. Solid state manipulation of lornoxicam for cocrystals--physicochemical characterization.
    Nijhawan M, Santhosh A, Babu PR, Subrahmanyam CV.
    Drug Dev Ind Pharm; 2014 Sep 06; 40(9):1163-72. PubMed ID: 23829186
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. New cocrystals of heterocyclic drugs: structural, antileishmanial, larvicidal and urease inhibition studies.
    Murtaza G, Khan M, Farooq S, Choudhary MI, Yousuf S.
    Acta Crystallogr C Struct Chem; 2023 Jun 01; 79(Pt 6):237-248. PubMed ID: 37140892
    [Abstract] [Full Text] [Related]

  • 28. A novel strategy for pharmaceutical cocrystal generation without knowledge of stoichiometric ratio: myricetin cocrystals and a ternary phase diagram.
    Hong C, Xie Y, Yao Y, Li G, Yuan X, Shen H.
    Pharm Res; 2015 Jan 01; 32(1):47-60. PubMed ID: 24939640
    [Abstract] [Full Text] [Related]

  • 29. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
    Eddleston MD, Madusanka N, Jones W.
    J Pharm Sci; 2014 Sep 01; 103(9):2865-2870. PubMed ID: 24824298
    [Abstract] [Full Text] [Related]

  • 30. Formation of Prenylated Chalcone Xanthohumol Cocrystals: Single Crystal X-Ray Diffraction, Vibrational Spectroscopic Study Coupled with Multivariate Analysis.
    Budziak I, Arczewska M, Kamiński DM.
    Molecules; 2019 Nov 21; 24(23):. PubMed ID: 31766540
    [Abstract] [Full Text] [Related]

  • 31. Cocrystals of quercetin with improved solubility and oral bioavailability.
    Smith AJ, Kavuru P, Wojtas L, Zaworotko MJ, Shytle RD.
    Mol Pharm; 2011 Oct 03; 8(5):1867-76. PubMed ID: 21846121
    [Abstract] [Full Text] [Related]

  • 32. First-line antituberculosis drug, pyrazinamide, its pharmaceutically relevant cocrystals and a salt.
    Sarmah KK, Rajbongshi T, Bhowmick S, Thakuria R.
    Acta Crystallogr B Struct Sci Cryst Eng Mater; 2017 Oct 01; 73(Pt 5):1007-1016. PubMed ID: 28981007
    [Abstract] [Full Text] [Related]

  • 33. Propensity of salicylamide and ethenzamide cocrystallization with aromatic carboxylic acids.
    Przybyłek M, Ziółkowska D, Mroczyńska K, Cysewski P.
    Eur J Pharm Sci; 2016 Mar 31; 85():132-40. PubMed ID: 26898408
    [Abstract] [Full Text] [Related]

  • 34. Piroxicam cocrystals with phenolic coformers: preparation, characterization, and dissolution properties.
    Emami S, Adibkia K, Barzegar-Jalali M, Siahi-Shadbad M.
    Pharm Dev Technol; 2019 Feb 31; 24(2):199-210. PubMed ID: 29557714
    [Abstract] [Full Text] [Related]

  • 35. Formation of itraconazole-succinic acid cocrystals by gas antisolvent cocrystallization.
    Ober CA, Gupta RB.
    AAPS PharmSciTech; 2012 Dec 31; 13(4):1396-406. PubMed ID: 23054991
    [Abstract] [Full Text] [Related]

  • 36. Physical stability enhancement of theophylline via cocrystallization.
    Trask AV, Motherwell WD, Jones W.
    Int J Pharm; 2006 Aug 31; 320(1-2):114-23. PubMed ID: 16769188
    [Abstract] [Full Text] [Related]

  • 37. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
    Basavoju S, Boström D, Velaga SP.
    Pharm Res; 2008 Mar 31; 25(3):530-41. PubMed ID: 17703346
    [Abstract] [Full Text] [Related]

  • 38. Inhibition of the spontaneous polymorphic transition of pyrazinamide γ form at room temperature by co-spray drying with 1,3-dimethylurea.
    Baaklini G, Dupray V, Coquerel G.
    Int J Pharm; 2015 Feb 01; 479(1):163-70. PubMed ID: 25556055
    [Abstract] [Full Text] [Related]

  • 39. Understanding the Effects of a Polymer on the Surface Dissolution of Pharmaceutical Cocrystals Using Combined Experimental and Molecular Dynamics Simulation Approaches.
    Kirubakaran P, Wang K, Rosbottom I, Cross RBM, Li M.
    Mol Pharm; 2020 Feb 03; 17(2):517-529. PubMed ID: 31887053
    [Abstract] [Full Text] [Related]

  • 40. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
    Tomaszewska I, Karki S, Shur J, Price R, Fotaki N.
    Int J Pharm; 2013 Sep 10; 453(2):380-8. PubMed ID: 23727143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.